{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T14:18:39Z","timestamp":1790605119149,"version":"4.1.0"},"reference-count":255,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T00:00:00Z","timestamp":1623024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Connective tissue disease (CTD) related interstitial lung disease (CTD-ILD) is one of the leading causes of morbidity and mortality of CTD. Clinically, CTD-ILD is highly heterogenous and involves rheumatic immunity and multiple manifestations of respiratory complications affecting the airways, vessels, lung parenchyma, pleura, and respiratory muscles. The major pathological features of CTD are chronic inflammation of blood vessels and connective tissues, which can affect any organ leading to multi-system damage. The human lung is particularly vulnerable to such damage because anatomically it is abundant with collagen and blood vessels. The complex etiology of CTD-ILD includes genetic risks, epigenetic changes, and dysregulated immunity, which interact leading to disease under various ill-defined environmental triggers. CTD-ILD exhibits a broad spectra of clinical manifestations: from asymptomatic to severe dyspnea; from single-organ respiratory system involvement to multi-organ involvement. The disease course is also featured by remissions and relapses. It can range from stability or slow progression over several years to rapid deterioration. It can also present clinically as highly progressive from the initial onset of disease. Currently, the diagnosis of CTD-ILD is primarily based on distinct pathology subtype(s), imaging, as well as related CTD and autoantibodies profiles. Meticulous comprehensive clinical and laboratory assessment to improve the diagnostic process and management strategies are much needed. In this review, we focus on examining the pathogenesis of CTD-ILD with respect to genetics, environmental factors, and immunological factors. We also discuss the current state of knowledge and elaborate on the clinical characteristics of CTD-ILD, distinct pathohistological subtypes, imaging features, and related autoantibodies. Furthermore, we comment on the identification of high-risk patients and address how to stratify patients for precision medicine management approaches.<\/jats:p>","DOI":"10.3389\/fimmu.2021.684699","type":"journal-article","created":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T07:17:56Z","timestamp":1623050276000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":111,"title":["Interstitial Lung Disease in Connective Tissue Disease: A Common Lesion With Heterogeneous Mechanisms and Treatment Considerations"],"prefix":"10.3389","volume":"12","author":[{"given":"Tihong","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanpeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwei","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shehabaldin","family":"Alqalyoobi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir A.","family":"Zeki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick S.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongwen","family":"Shuai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2005.00761.x","article-title":"The Respiratory System in Connective Tissue Disorders","volume":"60","author":"Crestani","year":"2005","journal-title":"Allergy"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2018.09.002","article-title":"Interstitial Lung Disease and Other Pulmonary Manifestations in Connective Tissue Diseases","volume":"94","author":"Mira-Avendano","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"B3","doi-asserted-by":"publisher","first-page":"h6819","DOI":"10.1136\/bmj.h6819","article-title":"Management of Interstitial Lung Disease Associated With Connective Tissue Disease","volume":"352","author":"Mathai","year":"2016","journal-title":"Bmj"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.644075","article-title":"Interstitial Lung Disease in the Context of Systemic Disease: Pathophysiology, Treatment and Outcomes","volume":"7","author":"Korsten","year":"2020","journal-title":"Front Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/biomedicines9010017","article-title":"Interstitial Pneumonia With Autoimmune Features: Why Rheumatologist-Pulmonologist Collaboration is Essential","volume":"9","author":"Sebastiani","year":"2020","journal-title":"Biomedicines"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801562","article-title":"MUC5B Promoter Variant and Rheumatoid Arthritis With Interstitial Lung Disease","volume":"379","author":"Juge","year":"2018","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2017.03.033","article-title":"The Role of Infection in Interstitial Lung Diseases: A Review","volume":"152","author":"Azadeh","year":"2017","journal-title":"Chest"},{"key":"B8","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.chest.2017.11.023","article-title":"Current Concepts in Pathogenesis, Diagnosis, and Management of Smoking-Related Interstitial Lung Diseases","volume":"154","author":"Kumar","year":"2018","journal-title":"Chest"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/art.22847","article-title":"B Cell Infiltration in Systemic Sclerosis-Associated Interstitial Lung Disease","volume":"56","author":"Lafyatis","year":"2007","journal-title":"Arthritis Rheum"},{"key":"B10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ejphar.2016.06.045","article-title":"Toll-Like Receptors in the Pathogenesis of Pulmonary Fibrosis","volume":"808","author":"Karampitsakos","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-2600(14)70124-9","article-title":"Effect of Telomere Length on Survival in Patients With Idiopathic Pulmonary Fibrosis: An Observational Cohort Study With Independent Validation","volume":"2","author":"Stuart","year":"2014","journal-title":"Lancet Respir Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/resp.12566","article-title":"Association Between Telomere Length and Survival in Patients With Idiopathic Pulmonary Fibrosis","volume":"20","author":"Dai","year":"2015","journal-title":"Respirology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0189467","article-title":"Short Telomere Length in IPF Lung Associates With Fibrotic Lesions and Predicts Survival","volume":"12","author":"Snetselaar","year":"2017","journal-title":"PloS One"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00308-2016","article-title":"Telomere-Related Lung Fibrosis is Diagnostically Heterogeneous But Uniformly Progressive","volume":"48","author":"Newton","year":"2016","journal-title":"Eur Respir J"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1013660","article-title":"A Common Muc5b Promoter Polymorphism and Pulmonary Fibrosis","volume":"364","author":"Seibold","year":"2011","journal-title":"New Engl J Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1013504","article-title":"A Variant in the Promoter of MUC5B and Idiopathic Pulmonary Fibrosis","volume":"364","author":"Zhang","year":"2011","journal-title":"N Engl J Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2609","article-title":"Genome-Wide Association Study Identifies Multiple Susceptibility Loci for Pulmonary Fibrosis","volume":"45","author":"Fingerlin","year":"2013","journal-title":"Nat Genet"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(13)70045-6","article-title":"Genetic Variants Associated With Idiopathic Pulmonary Fibrosis Susceptibility and Mortality: A Genome-Wide Association Study","volume":"1","author":"Noth","year":"2013","journal-title":"Lancet Respir Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e70621","DOI":"10.1371\/journal.pone.0070621","article-title":"The MUC5B Variant is Associated With Idiopathic Pulmonary Fibrosis But Not With Systemic Sclerosis Interstitial Lung Disease in the European Caucasian Population","volume":"8","author":"Borie","year":"2013","journal-title":"PloS One"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/resp.12466","article-title":"MUC5B Promoter Polymorphism in Japanese Patients With Idiopathic Pulmonary Fibrosis","volume":"20","author":"Horimasu","year":"2015","journal-title":"Respirology"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2012-201786","article-title":"Mucin 5B Promoter Polymorphism is Associated With Idiopathic Pulmonary Fibrosis But Not With Development of Lung Fibrosis in Systemic Sclerosis or Sarcoidosis","volume":"68","author":"Stock","year":"2013","journal-title":"Thorax"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-015-0829-6","article-title":"A Meta-Analysis Examining the Association Between the MUC5B Rs35705950 T\/G Polymorphism and Susceptibility to Idiopathic Pulmonary Fibrosis","volume":"64","author":"Lee","year":"2015","journal-title":"Inflammation Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/resp.12728","article-title":"Effect of Muc5b Promoter Polymorphism on Disease Predisposition and Survival in Idiopathic Interstitial Pneumonias","volume":"21","author":"Van","year":"2016","journal-title":"Respirology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1801641","DOI":"10.1183\/13993003.01641-2018","article-title":"Telomere Length and Genetic Variant Associations With Interstitial Lung Disease Progression and Survival","volume":"53","author":"Newton","year":"2019","journal-title":"Eur Respir J"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00004.2016","article-title":"Idiopathic Pulmonary Fibrosis: A Genetic Disease That Involves Mucociliary Dysfunction of the Peripheral Airways","volume":"96","author":"Evans","year":"2016","journal-title":"Physiol Rev"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1602314","DOI":"10.1136\/annrheumdis-2017-eular.5237","article-title":"Shared Genetic Predisposition in Rheumatoid Arthritis-Interstitial Lung Disease and Familial Pulmonary Fibrosis","volume":"49","author":"Juge","year":"2017","journal-title":"Eur Respir J"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu165","article-title":"Rheumatoid Arthritis-Related Interstitial Lung Disease: Associations, Prognostic Factors and Physiological and Radiological Characteristics\u2014A Large Multicentre UK Study","volume":"53","author":"Kelly","year":"2014","journal-title":"Rheumatology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1378\/chest.13-1394","article-title":"Functional Impact of a Spectrum of Interstitial Lung Abnormalities in Rheumatoid Arthritis","volume":"146","author":"Doyle","year":"2014","journal-title":"Chest"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067655","article-title":"A Polymorphism in the CTGF Promoter Region Associated With Systemic Sclerosis","volume":"357","author":"Fonseca","year":"2007","journal-title":"N Engl J Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar3809","article-title":"A Multicenter Study Confirms CD226 Gene Association With Systemic Sclerosis-Related Pulmonary Fibrosis","volume":"14","author":"Bossini-Castillo","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e1002178","DOI":"10.1371\/journal.pgen.1002178","article-title":"Identification of Novel Genetic Markers Associated With Clinical Phenotypes of Systemic Sclerosis Through a Genome-Wide Association Strategy","volume":"7","author":"Gorlova","year":"2011","journal-title":"PloS Genet"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-018-0104-8","article-title":"Genetic Predictors of Systemic Sclerosis-Associated Interstitial Lung Disease: A Review of Recent Literature","volume":"26","author":"Stock","year":"2018","journal-title":"Eur J Hum Genet"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4137\/ccrpm.s23283","article-title":"Genetics of Interstitial Lung Disease: Vol De Nuit (Night Flight)","volume":"9","author":"Furukawa","year":"2015","journal-title":"Clin Med Insights Circ Respir Pulm Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12863-016-0377-2","article-title":"Genome-Wide Imputation Study Identifies Novel HLA Locus for Pulmonary Fibrosis and Potential Role for Auto-Immunity in Fibrotic Idiopathic Interstitial Pneumonia","volume":"17","author":"Fingerlin","year":"2016","journal-title":"BMC Genet"},{"key":"B35","doi-asserted-by":"publisher","first-page":"R13","DOI":"10.1186\/ar1862","article-title":"In Adult Onset Myositis, the Presence of Interstitial Lung Disease and Myositis Specific\/Associated Antibodies are Governed by HLA Class II Haplotype, Rather Than by Myositis Subtype","volume":"8","author":"Chinoy","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/art.34657","article-title":"Brief Report: Association of HLA\u2013DRB1* 0101\/* 0405 With Susceptibility to Anti\u2013Melanoma Differentiation\u2013Associated Gene 5 Antibody\u2013Positive Dermatomyositis in the Japanese Population","volume":"64","author":"Gono","year":"2012","journal-title":"Arthritis Rheum"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.090303","article-title":"Hla-DRB1 Alleles and Rheumatoid Arthritis-Related Pulmonary Fibrosis","volume":"37","author":"Migita","year":"2010","journal-title":"J Rheumatol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e33133","DOI":"10.1371\/journal.pone.0033133","article-title":"Association of Human Leukocyte Antigen With Interstitial Lung Disease in Rheumatoid Arthritis: A Protective Role for Shared Epitope","volume":"7","author":"Furukawa","year":"2012","journal-title":"PloS One"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2012.07.006","article-title":"Different Risk Factors Between Interstitial Lung Disease and Airway Disease in Rheumatoid Arthritis","volume":"106","author":"Mori","year":"2012","journal-title":"Respir Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1097\/01.rhu.0000173620.95740.e2","article-title":"HLA Markers for Susceptibility and Expression in Scleroderma","volume":"32","author":"Gladman","year":"2005","journal-title":"J Rheumatol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.090377","article-title":"Association of HLA Class II Genes With Systemic Sclerosis in Spanish Patients","volume":"36","author":"Sime\u00f3n","year":"2009","journal-title":"J Rheumatol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/j.0001-2815.2004.00199.x","article-title":"Human Leukocyte Antigen Class II Associations With Systemic Sclerosis in South Africans","volume":"63","author":"Tikly","year":"2004","journal-title":"Tissue Antigens"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e87363","DOI":"10.1371\/journal.pone.0087363","article-title":"Association of HLA-DPB1 With Scleroderma and its Clinical Features in Chinese Population","volume":"9","author":"Wang","year":"2014","journal-title":"PloS One"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes149","article-title":"Up-Regulated Expression of HLA-DRB5 Transcripts and High Frequency of the HLA-DRB5* 01: 05 Allele in Scleroderma Patients With Interstitial Lung Disease","volume":"51","author":"Odani","year":"2012","journal-title":"Rheumatology"},{"key":"B45","doi-asserted-by":"publisher","first-page":"R85","DOI":"10.1186\/ar3809","article-title":"A Multicenter Study Confirms CD226 Gene Association With Systemic Sclerosis-Related Pulmonary Fibrosis","volume":"14","author":"Bossini-Castillo","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.100237","article-title":"Association of a Functional Polymorphism in the Matrix metalloproteinase-12 Promoter Region With Systemic Sclerosis in an Italian Population","volume":"37","author":"Manetti","year":"2010","journal-title":"J Rheumatol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kem355","article-title":"Genetic Polymorphisms in the Surfactant Proteins in Systemic Sclerosis in Japanese: T\/T Genotype at 1580 C\/T (Thr131Ile) in the SP-B Gene Reduces the Risk of Interstitial Lung Disease","volume":"47","author":"Sumita","year":"2008","journal-title":"Rheumatology"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/art.30415","article-title":"Association of Hepatocyte Growth Factor Promoter Polymorphism With Severity of Interstitial Lung Disease in Japanese Patients With Systemic Sclerosis","volume":"63","author":"Hoshino","year":"2011","journal-title":"Arthritis Rheum"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1002\/art.30640","article-title":"Evidence of the Contribution of the X Chromosome to Systemic Sclerosis Susceptibility: Association With the Functional IRAK1 196Phe\/532Ser Haplotype","volume":"63","author":"Dieude","year":"2011","journal-title":"Arthritis Rheum"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0b013e3181778cb5","article-title":"TCRBV20S1 and TCRBV3S1 Gene Segment Polymorphisms in Systemic Sclerosis","volume":"35","author":"Bredemeier","year":"2008","journal-title":"J Rheumatol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200901","article-title":"IRF5 Polymorphism Predicts Prognosis in Patients With Systemic Sclerosis","volume":"71","author":"Sharif","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2018.12.011","article-title":"Integrating Genomics Into Management of Fibrotic Interstitial Lung Disease","volume":"155","author":"Adegunsoye","year":"2019","journal-title":"Chest"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1042\/cs20150697","article-title":"Epigenetic Regulation of Cyclooxygenase-2 by Methylation of c8orf4 in Pulmonary Fibrosis","volume":"130","author":"Evans","year":"2016","journal-title":"Clin Sci (Lond)"},{"key":"B54","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/978-981-15-4494-1_6","article-title":"Research Advances on DNA Methylation in Idiopathic Pulmonary Fibrosis","author":"Luo","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201201-0077OC","article-title":"Altered DNA Methylation Profile in Idiopathic Pulmonary Fibrosis","volume":"186","author":"Sanders","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1080\/01902148.2019.1631906","article-title":"Schisandrin B Inhibits TGF-\u03b21-Induced Epithelial-Mesenchymal Transition in Human A549 Cells Through Epigenetic Silencing of ZEB1","volume":"45","author":"Zhuang","year":"2019","journal-title":"Exp Lung Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3109\/01902148.2015.1060275","article-title":"Histone Deacetylase Inhibitor Restores Surfactant Protein-C Expression in Alveolar-Epithelial Type II Cells and Attenuates Bleomycin-Induced Pulmonary Fibrosis In Vivo","volume":"41","author":"Ota","year":"2015","journal-title":"Exp Lung Res"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00128.2009","article-title":"Abrogation of TGF-beta1-induced Fibroblast-Myofibroblast Differentiation by Histone Deacetylase Inhibition","volume":"297","author":"Guo","year":"2009","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e621","DOI":"10.1038\/cddis.2013.146","article-title":"Histone Modifications are Responsible for Decreased Fas Expression and Apoptosis Resistance in Fibrotic Lung Fibroblasts","volume":"4","author":"Huang","year":"2013","journal-title":"Cell Death Dis"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2011.01.012","article-title":"MicroRNAs in Idiopathic Pulmonary Fibrosis","volume":"157","author":"Pandit","year":"2011","journal-title":"Transl Res"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2011.10.005","article-title":"Participation of miR-200 in Pulmonary Fibrosis","volume":"180","author":"Yang","year":"2012","journal-title":"Am J Pathol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200911-1698OC","article-title":"Inhibition and Role of let-7d in Idiopathic Pulmonary Fibrosis","volume":"182","author":"Pandit","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"B63","doi-asserted-by":"publisher","first-page":"e6718","DOI":"10.1371\/journal.pone.0006718","article-title":"Identification of Keratinocyte Growth Factor as a Target of microRNA-155 in Lung Fibroblasts: Implication in Epithelial-Mesenchymal Interactions","volume":"4","author":"Pottier","year":"2009","journal-title":"PloS One"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20100035","article-title":"miR-21 Mediates Fibrogenic Activation of Pulmonary Fibroblasts and Lung Fibrosis","volume":"207","author":"Liu","year":"2010","journal-title":"J Exp Med"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201502-088AW","article-title":"Viruses in Idiopathic Pulmonary Fibrosis. Etiology and Exacerbation","volume":"12","author":"Moore","year":"2015","journal-title":"Ann Am Thoracic Soc"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2013.09.005","article-title":"Interstitial Lung Diseases Induced or Exacerbated by DMARDS and Biologic Agents in Rheumatoid Arthritis: A Systematic Literature Review","volume":"43","author":"Roubille","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"B67","doi-asserted-by":"publisher","first-page":"3","DOI":"10.12746\/swrccc2016.0413.166","article-title":"The Effect of Disease Modifying Drugs on the Lung in Patients With Rheumatoid Arthritis","volume":"4","author":"Mahmood","year":"2016","journal-title":"Southwest Respir Crit Care Chronicles"},{"key":"B68","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3390\/jcm7100356","article-title":"Drug-Induced Interstitial Lung Disease: A Systematic Review","volume":"7","author":"Skeoch","year":"2018","journal-title":"J Clin Med"},{"key":"B69","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/resp.12576","article-title":"Smoking-Related Idiopathic Interstitial Pneumonia: A Review","volume":"21","author":"Margaritopoulos","year":"2016","journal-title":"Respirology"},{"key":"B70","article-title":"Smoking-Related Interstitial Lung Diseases","volume":"102","author":"Caminati","year":"2010","journal-title":"Pathologica"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.158.6.9804105","article-title":"Raghu: Increased Prevalence of Gastroesophageal Reflux in Patients With Idiopathic Pulmonary Fibrosis","volume":"158","author":"Tobin","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02316-2014","article-title":"Comorbidities in Idiopathic Pulmonary Fibrosis Patients: A Systematic Literature Review","volume":"46","author":"Raghu","year":"2015","journal-title":"Eur Respir J"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.06.00037005","article-title":"High Prevalence of Abnormal Acid Gastro-Oesophageal Reflux in Idiopathic Pulmonary Fibrosis","volume":"27","author":"Raghu","year":"2006","journal-title":"Eur Respir J"},{"key":"B74","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1465-9921-8-87","article-title":"Characterization of the Innate Immune Response to Chronic Aspiration in a Novel Rodent Model","volume":"8","author":"Appel","year":"2007","journal-title":"Respir Res"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(17)30219-9","article-title":"Antacid Therapy in Idiopathic Pulmonary Fibrosis: More Questions Than Answers","volume":"5","author":"Johannson","year":"2017","journal-title":"Lancet Respir Med"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e318173f64f","article-title":"Lung Injury and Recovery in a Murine Model of Unilateral Acid Aspiration: Functional, Biochemical, and Morphologic Characterization","volume":"108","author":"Amigoni","year":"2008","journal-title":"J Am Soc Anesthesiologists"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1378\/chest.07-1373","article-title":"Exposure of Airway Epithelium to Bile Acids Associated With Gastroesophageal Reflux Symptoms: A Relation to Transforming Growth Factor-\u03b21 Production and Fibroblast Proliferation","volume":"132","author":"Perng","year":"2007","journal-title":"Chest"},{"key":"B78","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.chest.2018.07.038","article-title":"Meta-Analysis of Gastroesophageal Reflux Disease and Idiopathic Pulmonary Fibrosis","volume":"155","author":"M\u00e9thot","year":"2019","journal-title":"Chest"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3325\/cmj.2014.55.83","article-title":"Helicobacter Pylori Infection and Respiratory Diseases: Actual Data and Directions for Future Studies","volume":"105","author":"Adriani","year":"2014","journal-title":"Minerva Med"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00033907","article-title":"Helicobacter Pylori Eradication in the Management of Idiopathic Pulmonary Fibrosis","volume":"30","author":"Ibrahim","year":"2007","journal-title":"Eur Respir J"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2014.08.002","article-title":"Nicotine Mediates Oxidative Stress and Apoptosis Through Cross Talk Between NOX1 and Bcl-2 in Lung Epithelial Cells","volume":"76","author":"Zanetti","year":"2014","journal-title":"Free Radic Biol Med"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00105.2007","article-title":"Comprehensive Gene Expression Profiling of Rat Lung Reveals Distinct Acute and Chronic Responses to Cigarette Smoke Inhalation","volume":"293","author":"Stevenson","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9343(02)01051-3","article-title":"Cigarette Smoking and the Risk of Rheumatoid Arthritis Among Postmenopausal Women: Results From the Iowa Women\u2019s Health Study","volume":"112","author":"Criswell","year":"2002","journal-title":"Am J Med"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.9.835","article-title":"Quantification of the Influence of Cigarette Smoking on Rheumatoid Arthritis: Results From a Population Based Case-Control Study, Using Incident Cases","volume":"62","author":"Stolt","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23837","article-title":"Impact and Timing of Smoking Cessation on Reducing Risk of Rheumatoid Arthritis Among Women in the Nurses\u2019 Health Studies","volume":"71","author":"Liu","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B86","doi-asserted-by":"crossref","DOI":"10.1164\/ajrccm-conference.2012.185.1_MeetingAbstracts.A6607","article-title":"The Role of Smoking in the Pathogenesis of Systemic Sclerosis Associated Lung Fibrosis","volume-title":"American Thoracic Society International Conference","author":"Margaritopoulos","year":"2012"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1002\/art.30071","article-title":"Cigarette Smoking in Patients With Systemic Sclerosis","volume":"63","author":"Hudson","year":"2011","journal-title":"Arthritis Rheum"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1002\/art.30352","article-title":"Cigarette Smoking in Patients With Systemic Sclerosis Reduces Overall Survival: Comment on the Article by Hudson et al","volume":"63","author":"Hissaria","year":"2011","journal-title":"Arthritis Rheum"},{"key":"B89","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2174\/1874306401206010063","article-title":"Drug Induced Interstitial Lung Disease","volume":"6","author":"Schwaiblmair","year":"2012","journal-title":"Open Respir Med J"},{"key":"B90","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1465-9921-13-39","article-title":"Drug-Induced Interstitial Lung Disease: Mechanisms and Best Diagnostic Approaches","volume":"13","author":"Matsuno","year":"2012","journal-title":"Respir Res"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201944","article-title":"HLA-A* 31: 01 and Methotrexate-Induced Interstitial Lung Disease in Japanese Rheumatoid Arthritis Patients: A Multidrug Hypersensitivity Marker","volume":"72","author":"Furukawa","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"B92","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-981-10-4466-3_1","article-title":"Definition and Pathogenesis of Drug-Induced Lung Injury: What Is DLI","author":"Nakamura","year":"2018","journal-title":"In: Drug Induced Lung Injury Springer"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-127-5-199709010-00003","article-title":"Risk Factors for Methotrexate-Induced Lung Injury in Patients With Rheumatoid Arthritis. A Multicenter, Case-Control Study. Methotrexate-Lung Study Group","volume":"127","author":"Alarc\u00f3n","year":"1997","journal-title":"Ann Intern Med"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/40.6.712","article-title":"Gold-Induced Pneumonitis: Computed Tomography Findings in a Patient With Rheumatoid Arthritis","volume":"40","author":"Sinha","year":"2001","journal-title":"Rheumatol (Oxford)"},{"key":"B95","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1080\/10408444.2018.1513991","article-title":"GOLD: Human Exposure and Update on Toxic Risks","volume":"48","author":"Lansdown","year":"2018","journal-title":"Crit Rev Toxicol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1136\/ard.40.2.136","article-title":"Relationship of Gold and Penicillamine Therapy to Diffuse Interstitial Lung Disease","volume":"40","author":"Scott","year":"1981","journal-title":"Ann Rheum Dis"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1378\/chest.101.4.1033","article-title":"Sulfasalazine-Induced Pulmonary Disease","volume":"101","author":"Hamadeh","year":"1992","journal-title":"Chest"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2011.01.016","article-title":"Tacrolimus-Induced Pulmonary Injury in Rheumatoid Arthritis Patients","volume":"24","author":"Koike","year":"2011","journal-title":"Pulm Pharmacol Ther"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-015-2865-6","article-title":"Characteristic Features of Tacrolimus-Induced Lung Disease in Rheumatoid Arthritis Patients","volume":"35","author":"Sasaki","year":"2016","journal-title":"Clin Rheumatol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h1269","article-title":"Methotrexate Use and Risk of Lung Disease in Psoriasis, Psoriatic Arthritis, and Inflammatory Bowel Disease: Systematic Literature Review and Meta-Analysis of Randomised Controlled Trials","volume":"350","author":"Conway","year":"2015","journal-title":"Bmj"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1002\/art.38322","article-title":"Methotrexate and Lung Disease in Rheumatoid Arthritis: A Meta-Analysis of Randomized Controlled Trials","volume":"66","author":"Conway","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.045211","article-title":"Methotrexate-Induced Lung Injury in Patients With Rheumatoid Arthritis Occurs With Peripheral Blood Lymphocyte Count Decrease","volume":"65","author":"Inokuma","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep050","article-title":"Clinical Expression of Leflunomide-Induced Pneumonitis","volume":"48","author":"Chikura","year":"2009","journal-title":"Rheumatol (Oxford)"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep227","article-title":"Factors Associated With Fatal Outcome of Leflunomide-Induced Lung Injury in Japanese Patients With Rheumatoid Arthritis","volume":"48","author":"Sato","year":"2009","journal-title":"Rheumatol (Oxford)"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep052","article-title":"Leflunomide-Induced Interstitial Lung Disease: Prevalence and Risk Factors in Japanese Patients With Rheumatoid Arthritis","volume":"48","author":"Sawada","year":"2009","journal-title":"Rheumatol (Oxford)"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00080209","article-title":"Rituximab-Induced Lung Disease: A Systematic Literature Review","volume":"35","author":"Liot\u00e9","year":"2010","journal-title":"Eur Respir J"},{"key":"B107","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/s13075-015-0835-7","article-title":"Incidence and Complications of Interstitial Lung Disease in Users of Tocilizumab, Rituximab, Abatacept and Anti-Tumor Necrosis Factor \u03b1 Agents, a Retrospective Cohort Study","volume":"17","author":"Curtis","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez337","article-title":"Methotrexate and Interstitial Lung Disease: Controversies and Questions. A Narrative Review of the Literature","volume":"58","author":"Fragoulis","year":"2019","journal-title":"Rheumatol (Oxford)"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa327","article-title":"Methotrexate and Risk of Interstitial Lung Disease and Respiratory Failure in Rheumatoid Arthritis: A Nationwide Population-Based Study","volume":"60","author":"Ibfelt","year":"2021","journal-title":"Rheumatol (Oxford)"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/41.3.262","article-title":"Investigation of the Chronic Pulmonary Effects of Low-Dose Oral Methotrexate in Patients With Rheumatoid Arthritis: A Prospective Study Incorporating HRCT Scanning and Pulmonary Function Tests","volume":"41","author":"Dawson","year":"2002","journal-title":"Rheumatology"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-028466","article-title":"Is Incident Rheumatoid Arthritis Interstitial Lung Disease Associated With Methotrexate Treatment? Results From a Multivariate Analysis in the ERAS and ERAN Inception Cohorts","volume":"9","author":"Kiely","year":"2019","journal-title":"BMJ Open"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1002\/art.37878","article-title":"Developing Better Biomarkers for Connective Tissue Disease-Associated Interstitial Lung Disease: Citrullinated hsp90 Autoantibodies in Rheumatoid Arthritis","volume":"65","author":"Deane","year":"2013","journal-title":"Arthritis Rheum"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1002\/art.20765","article-title":"Increased Cd4+ T Cell Infiltrates in Rheumatoid Arthritis-Associated Interstitial Pneumonitis Compared With Idiopathic Interstitial Pneumonitis","volume":"52","author":"Turesson","year":"2005","journal-title":"Arthritis Rheum"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1002\/art.21758","article-title":"Morphologic and Quantitative Assessment of CD20+ B Cell Infiltrates in Rheumatoid Arthritis-Associated Nonspecific Interstitial Pneumonia and Usual Interstitial Pneumonia","volume":"54","author":"Atkins","year":"2006","journal-title":"Arthritis Rheum"},{"key":"B115","doi-asserted-by":"publisher","first-page":"PA903","DOI":"10.1183\/1393003.congress-2017.PA903","article-title":"Nintedanib Inhibits Pro-Fibrotic Mediators From T Cells With Relevance to Connective Tissue Disease-Associated Interstitial Lung Disease","volume":"50","author":"Wollin","year":"2017","journal-title":"In: Eur Respir Soc"},{"key":"B116","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.clim.2010.06.017","article-title":"Alternatively Activated Alveolar Macrophages in Pulmonary Fibrosis\u2014Mediator Production and Intracellular Signal Transduction","volume":"137","author":"Pechkovsky","year":"2010","journal-title":"Clin Immunol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1055\/s-0034-1371527","article-title":"Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease","volume":"35","author":"Bonella","year":"2014","journal-title":"Semin Respir Crit Care Med"},{"key":"B118","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"An Official ATS\/ERS\/JRS\/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-Based Guidelines for Diagnosis and Management","volume":"183","author":"Raghu","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"B119","doi-asserted-by":"publisher","first-page":"692","DOI":"10.4049\/jimmunol.182.1.692","article-title":"Targeting TLR2 Attenuates Pulmonary Inflammation and Fibrosis by Reversion of Suppressive Immune Microenvironment","volume":"182","author":"Yang","year":"2009","journal-title":"J Immunol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1007\/s00418-008-0466-z","article-title":"TLR9 is Expressed in Idiopathic Interstitial Pneumonia and its Activation Promotes In Vitro Myofibroblast Differentiation","volume":"130","author":"Meneghin","year":"2008","journal-title":"Histochem Cell Biol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201304-0760OC","article-title":"The Toll-like Receptor 3 L412F Polymorphism and Disease Progression in Idiopathic Pulmonary Fibrosis","volume":"188","author":"O\u2019Dwyer","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035926","article-title":"Lipopolysaccharide Induces Lung Fibroblast Proliferation Through Toll-like Receptor 4 Signaling and the Phosphoinositide3-kinase-Akt Pathway","volume":"7","author":"He","year":"2012","journal-title":"PloS One"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4192","article-title":"Hyaluronan and TLR4 Promote surfactant-protein-C-positive Alveolar Progenitor Cell Renewal and Prevent Severe Pulmonary Fibrosis in Mice","volume":"22","author":"Liang","year":"2016","journal-title":"Nat Med"},{"key":"B124","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1755-1536-3-20","article-title":"Investigation of Toll-like Receptors in the Pathogenesis of Fibrotic and Granulomatous Disorders: A Bronchoalveolar Lavage Study","volume":"3","author":"Margaritopoulos","year":"2010","journal-title":"Fibrogenesis Tissue Repair"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2012.1374","article-title":"Expression Profiles of Toll-like Receptors in non-Small Cell Lung Cancer and Idiopathic Pulmonary Fibrosis","volume":"40","author":"Samara","year":"2012","journal-title":"Int J Oncol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2014.12.004","article-title":"Innate Immunity Alterations in Idiopathic Interstitial Pneumonias and Rheumatoid Arthritis-Associated Interstitial Lung Diseases","volume":"163","author":"Papanikolaou","year":"2015","journal-title":"Immunol Lett"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1097\/01.mcp.0000170522.71497.61","article-title":"Autoimmunity and Interstitial Lung Disease","volume":"11","author":"Jindal","year":"2005","journal-title":"Curr Opin Pulm Med"},{"key":"B128","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/nrrheum.2014.149","article-title":"Interstitial Lung Disease in Connective Tissue Disease\u2014Mechanisms and Management","volume":"10","author":"Wells","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2017.05.015","article-title":"Lung Manifestations in the Rheumatic Diseases","volume":"152","author":"Doyle","year":"2017","journal-title":"Chest"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An Official American Thoracic Society\/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"B131","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.ccm.2004.04.009","article-title":"Nonspecific Interstitial Pneumonia: A Real Clinical Entity","volume":"25","author":"Nagai","year":"2004","journal-title":"Clin Chest Med"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2012-0102-OA","article-title":"Pathologic Quantification of Connective Tissue Disease-Associated Versus Idiopathic Usual Interstitial Pneumonia","volume":"136","author":"Cipriani","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2012-0102-OA","article-title":"Pathologic Quantification of Connective Tissue Disease\u2013Associated Versus Idiopathic Usual Interstitial Pneumonia","volume":"136","author":"Cipriani","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"B134","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1183\/09031936.00060107","article-title":"Occult Connective Tissue Diseases Mimicking Idiopathic Interstitial Pneumonias","volume":"31","author":"Tzelepis","year":"2008","journal-title":"Eur Respir J"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1378\/chest.130.5.1489","article-title":"Interstitial Lung Disease in Primary Sjogren Syndrome","volume":"130","author":"Parambil","year":"2006","journal-title":"Chest"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-0444","article-title":": Rheumatoid Arthritis-Associated Interstitial Lung Disease: The Relevance of Histopathologic and Radiographic Pattern","volume":"136","author":"Kim","year":"2009","journal-title":"Chest"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1159\/000214841","article-title":"Pulmonary Manifestations of Sjogren\u2019s Syndrome","volume":"78","author":"Shi","year":"2009","journal-title":"Respiration"},{"key":"B138","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1378\/chest.08-2572","article-title":"Pathologic and Radiologic Differences Between Idiopathic and Collagen Vascular Disease-Related Usual Interstitial Pneumonia","volume":"136","author":"Song","year":"2009","journal-title":"Chest"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-0194","article-title":"Connective Tissue Disease-Associated Interstitial Lung Disease: A Call for Clarification","volume":"138","author":"Fischer","year":"2010","journal-title":"Chest"},{"key":"B140","doi-asserted-by":"publisher","first-page":"21137","DOI":"10.1038\/s41598-020-78140-5","article-title":"Histologic Features Suggesting Connective Tissue Disease in Idiopathic Pulmonary Fibrosis","volume":"10","author":"Kim","year":"2020","journal-title":"Sci Rep"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3003.2000.15b31.x","article-title":"Acute Interstitial Pneumonia","volume":"15","author":"Bouros","year":"2000","journal-title":"Eur Respir J"},{"key":"B142","article-title":"Cryptogenic Organizing Pneumonia","volume-title":"Statpearls","author":"Chandra","year":"2021"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20160723","article-title":"Radio-Pathological Correlation of Organizing Pneumonia (OP): A Pictorial Review","volume":"90","author":"Zare Mehrjardi","year":"2017","journal-title":"Br J Radiol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0249300","article-title":"Clinical Features of Acute Fibrinous and Organizing Pneumonia: An Early Histologic Pattern of Various Acute Inflammatory Lung Diseases","volume":"16","author":"Onishi","year":"2021","journal-title":"PloS One"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200703-463pp","article-title":"Acute Exacerbations of Idiopathic Pulmonary Fibrosis","volume":"176","author":"Collard","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"B146","doi-asserted-by":"publisher","first-page":"17074","DOI":"10.1038\/nrdp.2017.74","article-title":"Idiopathic Pulmonary Fibrosis","volume":"3","author":"Martinez","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"B147","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/00000478-200001000-00003","article-title":"Idiopathic Nonspecific Interstitial Pneumonia: Prognostic Significance of Cellular and Fibrosing Patterns: Survival Comparison With Usual Interstitial Pneumonia and Desquamative Interstitial Pneumonia","volume":"24","author":"Travis","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200611-1685oc","article-title":"Idiopathic Nonspecific Interstitial Pneumonia: Report of an American Thoracic Society Project","volume":"177","author":"Travis","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1378\/chest.122.6.2150","article-title":"Lymphoid Interstitial Pneumonia: A Narrative Review","volume":"122","author":"Swigris","year":"2002","journal-title":"Chest"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2016.04.009","article-title":"Lymphocytic Interstitial Pneumonia","volume":"37","author":"Panchabhai","year":"2016","journal-title":"Clin Chest Med"},{"key":"B151","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/RTI.0000000000000191","article-title":"The Spectrum of Interstitial Lung Disease in Connective Tissue Disease","volume":"31","author":"Henry","year":"2016","journal-title":"J Thoracic Imaging"},{"key":"B152","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1053\/j.sult.2013.10.010","article-title":"Connective Tissue Disease-Associated Interstitial Pneumonia and Idiopathic Interstitial Pneumonia: Similarity and Difference","volume":"35","author":"Bryson","year":"2014","journal-title":"Semin Ultrasound CT MR"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2014.11.026","article-title":"Interstitial Lung Disease in Anti-Synthetase Syndrome: Initial and Follow-Up CT Findings","volume":"84","author":"Debray","year":"2015","journal-title":"Eur J Radiol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2006.069237","article-title":"Interstitial Lung Disease and anti-Jo-1 Antibodies: Difference Between Acute and Gradual Onset","volume":"63","author":"Tillie-Leblond","year":"2008","journal-title":"Thorax"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.17.18384","article-title":"CT Features of the Usual Interstitial Pneumonia Pattern: Differentiating Connective Tissue Disease\u2013Associated Interstitial Lung Disease From Idiopathic Pulmonary Fibrosis","volume":"210","author":"Chung","year":"2018","journal-title":"Am J Roentgenol"},{"key":"B156","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/978-981-13-2544-1_13","article-title":"Imaging of Interstitial Lung Diseases","volume-title":"Thoracic Imaging","author":"Chawla","year":"2019"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1002\/art.38390","article-title":"Prediction of Pulmonary Complications and Long-Term Survival in Systemic Sclerosis","volume":"66","author":"Nihtyanova","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"B158","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nrrheum.2009.238","article-title":"Autoantibodies as Predictive Tools in Systemic Sclerosis","volume":"6","author":"Nihtyanova","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161908","article-title":"Clinical Features of Idiopathic Interstitial Pneumonia With Systemic Sclerosis-Related Autoantibody in Comparison With Interstitial Pneumonia With Systemic Sclerosis","volume":"11","author":"Yamakawa","year":"2016","journal-title":"PloS One"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1016\/j.canrad.2006.09.088","article-title":"Monospecific Anti-Ro52\/TRIM21 Antibodies in a Tri-Nation Cohort of 1574 Systemic Sclerosis Subjects: Evidence of an Association With Interstitial Lung Disease and Worse Survival","volume":"33","author":"Wodkowski","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew320","article-title":"The Utility of Comprehensive Autoantibody Testing to Differentiate Connective Tissue Disease Associated and Idiopathic Interstitial Lung Disease Subgroup Cases","volume":"56","author":"Cotton","year":"2017","journal-title":"Rheumatology"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2003.12028.x","article-title":"The Prevalence and Clinical Significance of Anti-U1 Rna Antibodies in Patients With Systemic Sclerosis","volume":"120","author":"Asano","year":"2003","journal-title":"J Invest Dermatol"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keg170","article-title":"The Association of Antinuclear Antibodies With Organ Involvement and Survival in Systemic Sclerosis","volume":"42","author":"Hesselstrand and","year":"2003","journal-title":"Rheumatology"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-215004","article-title":"Anti-Ro52 Autoantibodies are Associated With Interstitial Lung Disease and More Severe Disease in Patients With Juvenile Myositis","volume":"78","author":"Sabbagh","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"B165","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1093\/rheumatology\/kex021","article-title":"A Longitudinal Cohort Study of the Anti-Synthetase Syndrome: Increased Severity of Interstitial Lung Disease in Black Patients and Patients With anti-PL7 and anti-PL12 Autoantibodies","volume":"56","author":"Pinal-Fernandez","year":"2017","journal-title":"Rheumatology"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150844","article-title":"Rituximab in the Treatment of Jo1 Antibody\u2013Associated Antisynthetase Syndrome: Anti-Ro52 Positivity as a Marker for Severity and Treatment Response","volume":"43","author":"Bauhammer","year":"2016","journal-title":"J Rheumatol"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1080\/08916930600623791","article-title":"In Patients With Antisynthetase Syndrome the Occurrence of anti-Ro\/SSA Antibodies Causes a More Severe Interstitial Lung Disease","volume":"39","author":"La Corte","year":"2006","journal-title":"Autoimmunity"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-009-0884-9","article-title":"Characteristics of Interstitial Lung Disease in SS-A Positive\/Jo-1 Positive Inflammatory Myopathy Patients","volume":"29","author":"V\u00e1ncsa","year":"2009","journal-title":"Rheumatol Int"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2011.09.008","article-title":"Short-Term and Long-Term Outcome of Anti-Jo1-positive Patients With anti-Ro52 Antibody","volume":"41","author":"Marie","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2016.09.006","article-title":"Autoantibody to Scaffold Attachment Factor B (SAFB): A Novel Connective Tissue Disease-Related Autoantibody Associated With Interstitial Lung Disease","volume":"76","author":"Takeuchi","year":"2017","journal-title":"J Autoimmun"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201411-1950OC","article-title":"Detection of Rheumatoid Arthritis\u2013Interstitial Lung Disease is Enhanced by Serum Biomarkers","volume":"191","author":"Doyle","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu165","article-title":"Rheumatoid Arthritis-Related Interstitial Lung Disease: Associations, Prognostic Factors and Physiological and Radiological Characteristics\u2013a Large Multicentre UK Study","volume":"53","author":"Kelly","year":"2014","journal-title":"Rheumatol (Oxford)"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201411-1950OC","article-title":"Detection of Rheumatoid Arthritis-Interstitial Lung Disease Is Enhanced by Serum Biomarkers","volume":"191","author":"Doyle","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2007.59","article-title":"Progressive Preclinical Interstitial Lung Disease in Rheumatoid Arthritis","volume":"168","author":"Gochuico","year":"2008","journal-title":"Arch Internal Med"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev300","article-title":"Associations Between anti-Ro52 Antibodies and Lung Fibrosis in Mixed Connective Tissue Disease","volume":"55","author":"Gunnarsson","year":"2016","journal-title":"Rheumatol (Oxford)"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2006.02.026","article-title":"Idiopathic Pulmonary Fibrosis Related to Endothelial Injury and Antiendothelial Cell Antibodies","volume":"67","author":"Magro","year":"2006","journal-title":"Hum Immunol"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-2600(19)30480-1","article-title":"Systemic Sclerosis-Associated Interstitial Lung Disease","volume":"8","author":"Perelas","year":"2020","journal-title":"Lancet Respir Med"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1378\/chest.15-1145","article-title":"Clinical Characteristics of Connective Tissue Disease-Associated Interstitial Lung Disease in 1,044 Chinese Patients","volume":"149","author":"Hu","year":"2016","journal-title":"Chest"},{"key":"B179","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1183\/16000617.0100-2018","article-title":"Fibrosing Interstitial Lung Diseases: Knowns and Unknowns","volume":"28","author":"Cottin","year":"2019","journal-title":"Eur Respir Rev"},{"key":"B180","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12931-020-1296-3","article-title":"Progression of Fibrosing Interstitial Lung Disease","volume":"21","author":"Wong","year":"2020","journal-title":"Respir Res"},{"key":"B181","doi-asserted-by":"publisher","first-page":"180076","DOI":"10.1183\/16000617.0076-2018","article-title":"Presentation, Diagnosis and Clinical Course of the Spectrum of Progressive-Fibrosing Interstitial Lung Diseases","volume":"27","author":"Cottin","year":"2018","journal-title":"Eur Respir Rev"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-213708","article-title":"Short-Term Progression of Interstitial Lung Disease in Systemic Sclerosis Predicts Long-Term Survival in Two Independent Clinical Trial Cohorts","volume":"78","author":"Volkmann","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2018.02.008","article-title":"Predictors of Morbidity and Mortality in Early Systemic Sclerosis: Long-Term Follow-Up Data From a Single-Centre Inception Cohort","volume":"17","author":"Panopoulos","year":"2018","journal-title":"Autoimmun Rev"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1002\/art.40130","article-title":"Short-Term Pulmonary Function Trends are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis","volume":"69","author":"Goh","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(17)30433-2","article-title":"Diagnostic Criteria for Idiopathic Pulmonary Fibrosis: A Fleischner Society White Paper","volume":"6","author":"Lynch","year":"2018","journal-title":"Lancet Respir Med"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201809-1652OC","article-title":"Imaging Patterns are Associated With Interstitial Lung Abnormality Progression and Mortality","volume":"200","author":"Putman","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1216076","article-title":"MUC5B Promoter Polymorphism and Interstitial Lung Abnormalities","volume":"368","author":"Hunninghake","year":"2013","journal-title":"New Engl J Med"},{"key":"B188","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12916-016-0739-7","article-title":"Evaluation of Computer-Based Computer Tomography Stratification Against Outcome Models in Connective Tissue Disease-Related Interstitial Lung Disease: A Patient Outcome Study","volume":"14","author":"Jacob","year":"2016","journal-title":"BMC Med"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2020.01.006","article-title":"Circulating Lung Biomarkers in Idiopathic Lung Fibrosis and Interstitial Lung Diseases Associated With Connective Tissue Diseases: Where do We Stand","volume":"50","author":"Elhai","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"B190","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.pharmthera.2019.05.014","article-title":"Review: Serum Biomarkers in Idiopathic Pulmonary Fibrosis and Systemic Sclerosis Associated Interstitial Lung Disease - Frontiers and Horizons","volume":"202","author":"Jee","year":"2019","journal-title":"Pharmacol Ther"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202103-0559UP","article-title":"Update in Interstitial Lung Disease 2020","author":"Podolanczuk","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201907-1343LE","article-title":"Circulating Plasma Biomarkers of Progressive Interstitial Lung Disease","volume":"201","author":"Alqalyoobi","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2020.03.037","article-title":"Diagnostic and Prognostic Biomarkers for Chronic Fibrosing Interstitial Lung Diseases With a Progressive Phenotype","volume":"158","author":"Inoue","year":"2020","journal-title":"Chest"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4759040","article-title":"Comparative Study of Circulating Mmp-7, CCL18, Kl-6, SP-A, and SP-D as Disease Markers of Idiopathic Pulmonary Fibrosis","author":"Hamai","year":"2016","journal-title":"Dis Markers"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.165.3.2107134","article-title":"Comparative Study of KL-6, Surfactant protein-A, Surfactant protein-D, and Monocyte Chemoattractant Protein-1 as Serum Markers for Interstitial Lung Diseases","volume":"165","author":"Ohnishi","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2006.01704.x","article-title":"Increased Levels of KL-6 and Subsequent Mortality in Patients With Interstitial Lung Diseases","volume":"260","author":"Satoh","year":"2006","journal-title":"J Intern Med"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2014.04.009","article-title":"Baseline KL-6 Predicts Increased Risk for Acute Exacerbation of Idiopathic Pulmonary Fibrosis","volume":"108","author":"Ohshimo","year":"2014","journal-title":"Respir Med"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1111\/crj.12946","article-title":"The Serum KL-6 Levels in Untreated Idiopathic Pulmonary Fibrosis can Naturally Decline in Association With Disease Progression","volume":"12","author":"Ishii","year":"2018","journal-title":"Clin Respir J"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1002\/art.40815","article-title":"Performance of Candidate Serum Biomarkers for Systemic Sclerosis\u2013Associated Interstitial Lung Disease","volume":"71","author":"Elhai","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"B200","first-page":"S","article-title":"Follow-Up of Serum KL-6 Lung Fibrosis Biomarker Levels in 173 Patients With Systemic Sclerosis","volume":"32","author":"Kum\u00e1novics","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-018-3987-3","article-title":"Elevated Serum Krebs Von Den Lungen-6 in Systemic Sclerosis: A Marker of Lung Fibrosis and Severity of the Disease","volume":"38","author":"Benyamine","year":"2018","journal-title":"Rheumatol Int"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000013542","article-title":"Serial Measurements of KL-6 for Monitoring Activity and Recurrence of Interstitial Pneumonia With anti-aminoacyl-tRNA Synthetase Antibody: A Retrospective Cohort Study","volume":"97","author":"Yamaguchi","year":"2018","journal-title":"Med (Baltimore)"},{"key":"B203","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.chest.2016.03.004","article-title":"High Level of Chemokine CCL18 Is Associated With Pulmonary Function Deterioration, Lung Fibrosis Progression, and Reduced Survival in Systemic Sclerosis","volume":"150","author":"Hoffmann-Vold","year":"2016","journal-title":"Chest"},{"key":"B204","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1371\/journal.pmed.0050093","article-title":"MMP1 and MMP7 as Potential Peripheral Blood Biomarkers in Idiopathic Pulmonary Fibrosis","volume":"5","author":"Rosas","year":"2008","journal-title":"PloS Med"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.1111\/resp.12920","article-title":"Validation of the Prognostic Value of MMP-7 in Idiopathic Pulmonary Fibrosis","volume":"22","author":"Tzouvelekis","year":"2017","journal-title":"Respirology"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.02.00081102","article-title":"Serum Surfactant Proteins-a and -D as Biomarkers in Idiopathic Pulmonary Fibrosis","volume":"19","author":"Greene","year":"2002","journal-title":"Eur Respir J"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez230","article-title":"Biomarkers in Systemic Sclerosis-Associated Interstitial Lung Disease: Review of the Literature","volume":"58","author":"Bonhomme","year":"2019","journal-title":"Rheumatol (Oxford)"},{"key":"B208","doi-asserted-by":"publisher","first-page":"180071","DOI":"10.1183\/16000617.0071-2018","article-title":"Acute Exacerbations of Progressive-Fibrosing Interstitial Lung Diseases","volume":"27","author":"Kolb","year":"2018","journal-title":"Eur Respir Rev"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2015.01.002","article-title":"Management of Connective Tissue Disease\u2013associated Interstitial Lung Disease","volume":"41","author":"Chartrand","year":"2015","journal-title":"Rheumatic Dis Clinics"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-019-01178-x","article-title":"Current and Emerging\u00a0Drug Therapies for Connective Tissue Disease-Interstitial Lung Disease (CTD-ILD)","volume":"79","author":"Jee","year":"2019","journal-title":"Drugs"},{"key":"B211","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.path.2019.11.006","article-title":"Pathology of Idiopathic Interstitial Pneumonias","volume":"13","author":"Zaizen","year":"2020","journal-title":"Surg Pathol Clinics"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1903076","article-title":"Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease","volume":"380","author":"Distler","year":"2019","journal-title":"N Engl J Med"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1038\/srep33226","article-title":"Pirfenidone in Patients With Rapidly Progressive Interstitial Lung Disease Associated With Clinically Amyopathic Dermatomyositis","volume":"6","author":"Li","year":"2016","journal-title":"Sci Rep"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-2600(19)30341-8","article-title":"Pirfenidone in Patients With Unclassifiable Progressive Fibrosing Interstitial Lung Disease: A Double-Blind, Randomised, Placebo-Controlled, Phase 2 Trial","volume":"8","author":"Maher","year":"2020","journal-title":"Lancet Respir Med"},{"key":"B215","first-page":"4357","article-title":"Interstitial Lung Disease in Dermatomyositis and Polymyositis: Treatment","author":"Dellaripa","year":"2015","journal-title":"UpToDate"},{"key":"B216","article-title":"Interstitial Lung Disease Associated With Sj\u00f6gren\u2019s Syndrome: Management and Prognosis","author":"de Carvalho","year":"2020","journal-title":"UpToDate"},{"key":"B217","article-title":"Interstitial Lung Disease in Rheumatoid Arthritis","volume":"7","author":"Lake","year":"2011","journal-title":"UpToDate"},{"key":"B218","article-title":"Treatment and Prognosis of Interstitial Lung Disease in Systemic Sclerosis (Scleroderma)","author":"Varga","year":"2021","journal-title":"UpToDate"},{"key":"B219","doi-asserted-by":"publisher","first-page":"Cd010908","DOI":"10.1002\/14651858.CD010908.pub2","article-title":"Cyclophosphamide for Connective Tissue Disease-Associated Interstitial Lung Disease","volume":"1","author":"Barnes","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055120","article-title":"Cyclophosphamide Versus Placebo in Scleroderma Lung Disease","volume":"354","author":"Tashkin","year":"2006","journal-title":"New Engl J Med"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key151","article-title":"Ongoing Clinical Trials and Treatment Options for Patients With Systemic Sclerosis-Associated Interstitial Lung Disease","volume":"58","author":"Khanna","year":"2019","journal-title":"Rheumatol (Oxford)"},{"key":"B222","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1056\/NEJMc061920","article-title":"Cyclophosphamide in Scleroderma Lung Disease","volume":"355","author":"Sullivan","year":"2006","journal-title":"N Engl J Med"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-2600(16)30152-7","article-title":"Mycophenolate Mofetil Versus Oral Cyclophosphamide in Scleroderma-Related Interstitial Lung Disease (SLS II): A Randomised Controlled, Double-Blind, Parallel Group Trial","volume":"4","author":"Tashkin","year":"2016","journal-title":"Lancet Respir Med"},{"key":"B224","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1016\/s2213-2600(16)30318-6","article-title":"Mycophenolate Mofetil for Scleroderma-Related Interstitial Lung Disease","volume":"4","author":"Zaheen","year":"2016","journal-title":"Lancet Respir Med"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.1002\/art.40114","article-title":"Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis-Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and II","volume":"69","author":"Volkmann","year":"2017","journal-title":"Arthritis Rheumatol (Hoboken NJ)"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2016.11.007","article-title":"Azathioprine Response in Patients With Fibrotic Connective Tissue Disease-Associated Interstitial Lung Disease","volume":"121","author":"Oldham","year":"2016","journal-title":"Respir Med"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.1002\/art.22744","article-title":"Twelve-Month Azathioprine as Maintenance Therapy in Early Diffuse Systemic Sclerosis Patients Treated for 1-Year With Low Dose Cyclophosphamide Pulse Therapy","volume":"25","author":"Paone","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2012.09.027","article-title":"Calcineurin Inhibitors in a Cohort of Patients With Antisynthetase-Associated Interstitial Lung Disease","volume":"31","author":"Labirua-Iturburu","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez394","article-title":"Impact of Adding Tacrolimus to Initial Treatment of Interstitial Pneumonitis in Polymyositis\/Dermatomyositis: A Single-Arm Clinical Trial","volume":"59","author":"Takada","year":"2020","journal-title":"Rheumatol (Oxford)"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.1002\/art.41105","article-title":"Multicenter Prospective Study of the Efficacy and Safety of Combined Immunosuppressive Therapy With High-Dose Glucocorticoid, Tacrolimus, and Cyclophosphamide in Interstitial Lung Diseases Accompanied by Anti-Melanoma Differentiation-Associated Gene 5-Positive Dermatomyositis","volume":"72","author":"Tsuji","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.1111\/resp.12214","article-title":"Rituximab in Severe, Treatment-Refractory Interstitial Lung Disease","volume":"19","author":"Keir","year":"2014","journal-title":"Respirology"},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew195","article-title":"Rituximab in Autoimmune Connective Tissue Disease-Associated Interstitial Lung Disease","volume":"55","author":"Sharp","year":"2016","journal-title":"Rheumatol (Oxford)"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-019-04784-y","article-title":"The Chinese Herb Tripterygium Wilfordii Hook F for the Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease: Data From a Chinese Eustar Center","volume":"39","author":"Yang","year":"2020","journal-title":"Clin Rheumatol"},{"key":"B234","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.120725","article-title":"Serum Interleukin 6 is Predictive of Early Functional Decline and Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis","volume":"40","author":"De Lauretis","year":"2013","journal-title":"J Rheumatol"},{"key":"B235","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-2600(20)30318-0","article-title":"Tocilizumab in Systemic Sclerosis: A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial","volume":"8","author":"Khanna","year":"2020","journal-title":"Lancet Respir Med"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00232-4","article-title":"Safety and Efficacy of Subcutaneous Tocilizumab in Adults With Systemic Sclerosis (faSScinate): A Phase 2, Randomised, Controlled Trial","volume":"387","author":"Khanna","year":"2016","journal-title":"Lancet"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211682","article-title":"Safety and Efficacy of Subcutaneous Tocilizumab in Systemic Sclerosis: Results From the Open-Label Period of a Phase II Randomised Controlled Trial (Fasscinate)","volume":"77","author":"Khanna","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102830","article-title":"Efficacy and Safety of Abatacept in Interstitial Lung Disease of Rheumatoid Arthritis: A Systematic Literature Review","volume":"20","author":"Vicente-Rabaneda","year":"2021","journal-title":"Autoimmun Rev"},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa621","article-title":"Abatacept in Interstitial Lung Disease Associated With Rheumatoid Arthritis: National Multicenter Study of 263 Patients","volume":"59","author":"Fern\u00e1ndez-D\u00edaz","year":"2020","journal-title":"Rheumatol (Oxford)"},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908681","article-title":"Nintedanib in Progressive Fibrosing Interstitial Lung Diseases","volume":"381","author":"Flaherty","year":"2019","journal-title":"New Engl J Med"},{"key":"B241","article-title":"Prognosis and Treatment of Interstitial Lung Disease in Systemic Sclerosis (Scleroderma)","volume":"4375","author":"Varga","year":"2011","journal-title":"UpToDate"},{"key":"B242","article-title":"Clinical Experience With Pirfenidone in Five Patients With Scleroderma-Related Interstitial Lung Disease","volume":"31","author":"Miura","year":"2014","journal-title":"Sarcoidosis Vasculitis Diffuse Lung Diseases: Off J WASOG"},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-020-04565-w","article-title":"Efficacy and Safety of Pirfenidone in Systemic Sclerosis-Related Interstitial Lung Disease-a Randomised Controlled Trial","volume":"40","author":"Acharya","year":"2020","journal-title":"Rheumatol Int"},{"key":"B244","doi-asserted-by":"publisher","DOI":"10.7573\/dic.2020-8-6","article-title":"Antifibrotic Drugs in Connective Tissue Disease-Related Interstitial Lung Disease (CTD-ILD): From Mechanistic Insights to Therapeutic Applications","volume":"10","author":"Erre","year":"2021","journal-title":"Drugs Context"},{"key":"B245","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa123","article-title":"Efficacy of Plasma Exchange in anti-MDA5-positive Dermatomyositis With Interstitial Lung Disease Under Combined Immunosuppressive Treatment","volume":"59","author":"Shirakashi","year":"2020","journal-title":"Rheumatol (Oxford)"},{"key":"B246","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217058","article-title":"Predictive Factors for Treatment-Related Mortality and Major Adverse Events After Autologous Haematopoietic Stem Cell Transplantation for Systemic Sclerosis: Results of a Long-Term Follow-Up Multicentre Study","volume":"79","author":"van Bijnen","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B247","doi-asserted-by":"publisher","first-page":"1901760","DOI":"10.1183\/13993003.01760-2019","article-title":"Acute Exacerbation of Idiopathic Pulmonary Fibrosis: International Survey and Call for Harmonisation","volume":"55","author":"Kreuter","year":"2020","journal-title":"Eur Respir J"},{"key":"B248","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201604-0801CI","article-title":"Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report","volume":"194","author":"Collard","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"B249","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201010-1752OC","article-title":"Viral Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis","volume":"183","author":"Wootton","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"B250","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.21037\/jtd.2019.03.28","article-title":"Acute Exacerbation of Interstitial Lung Diseases Secondary to Systemic Rheumatic Diseases: A Prospective Study and Review of the Literature","volume":"11","author":"Manfredi","year":"2019","journal-title":"J\u00a0Thoracic Dis"},{"key":"B251","doi-asserted-by":"publisher","DOI":"10.1159\/000329893","article-title":"Clinical Features and Outcome of Acute Exacerbation of Interstitial Pneumonia: Collagen Vascular Diseases-Related Versus Idiopathic","volume":"83","author":"Tachikawa","year":"2012","journal-title":"Respiration"},{"key":"B252","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2008.12.019","article-title":"Acute Exacerbation of Interstitial Pneumonia Associated With Collagen Vascular Diseases","volume":"103","author":"Suda","year":"2009","journal-title":"Respir Med"},{"key":"B253","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-2600(14)70069-4","article-title":"Lung Microbiome and Disease Progression in Idiopathic Pulmonary Fibrosis: An Analysis of the COMET Study","volume":"2","author":"Han","year":"2014","journal-title":"Lancet Respir Med"},{"key":"B254","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12931-017-0511-3","article-title":"Changes in the Respiratory Microbiome During Acute Exacerbations of Idiopathic Pulmonary Fibrosis","volume":"18","author":"Molyneaux","year":"2017","journal-title":"Respir Res"},{"key":"B255","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201607-1408OC","article-title":"Host-Microbial Interactions in Idiopathic Pulmonary Fibrosis","volume":"195","author":"Molyneaux","year":"2017","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.684699\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T07:18:08Z","timestamp":1623050288000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.684699\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,7]]},"references-count":255,"alternative-id":["10.3389\/fimmu.2021.684699"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.684699","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,7]]},"article-number":"684699"}}